PubMed:32176772 / 750-870
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 73-83 | CHEBI:33282 | denotes | antibiotic |
T9 | 73-83 | CHEBI:33282 | denotes | antibiotic |
LitCovid-PAS-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
EnjuParser_T153 | 0-4 | JJS | denotes | Most |
EnjuParser_T154 | 5-13 | NNS | denotes | patients |
EnjuParser_T155 | 14-22 | VBD | denotes | received |
EnjuParser_T156 | 23-32 | JJ | denotes | antiviral |
EnjuParser_T157 | 33-40 | NN | denotes | therapy |
EnjuParser_T158 | 41-42 | -LRB- | denotes | ( |
EnjuParser_T159 | 42-44 | CD | denotes | 66 |
EnjuParser_T160 | 45-46 | -LRB- | denotes | [ |
EnjuParser_T161 | 46-50 | CD | denotes | 98.5 |
EnjuParser_T162 | 50-51 | NN | denotes | % |
EnjuParser_T163 | 51-52 | -RRB- | denotes | ] |
EnjuParser_T164 | 53-55 | IN | denotes | of |
EnjuParser_T165 | 56-58 | CD | denotes | 67 |
EnjuParser_T166 | 59-67 | NNS | denotes | patients |
EnjuParser_T167 | 67-68 | -RRB- | denotes | ) |
EnjuParser_T168 | 69-72 | CC | denotes | and |
EnjuParser_T169 | 73-83 | JJ | denotes | antibiotic |
EnjuParser_T170 | 84-91 | NN | denotes | therapy |
EnjuParser_T171 | 92-93 | -LRB- | denotes | ( |
EnjuParser_T172 | 93-95 | CD | denotes | 66 |
EnjuParser_T173 | 96-97 | -LRB- | denotes | [ |
EnjuParser_T174 | 97-101 | CD | denotes | 98.5 |
EnjuParser_T175 | 101-102 | NN | denotes | % |
EnjuParser_T176 | 102-103 | -RRB- | denotes | ] |
EnjuParser_T177 | 104-106 | IN | denotes | of |
EnjuParser_T178 | 107-109 | CD | denotes | 67 |
EnjuParser_T179 | 110-118 | NNS | denotes | patients |
EnjuParser_T180 | 118-119 | -RRB- | denotes | ) |
EnjuParser_R151 | EnjuParser_T154 | EnjuParser_T153 | arg1Of | patients,Most |
EnjuParser_R152 | EnjuParser_T154 | EnjuParser_T155 | arg1Of | patients,received |
EnjuParser_R153 | EnjuParser_T168 | EnjuParser_T155 | arg2Of | and,received |
EnjuParser_R154 | EnjuParser_T157 | EnjuParser_T156 | arg1Of | therapy,antiviral |
EnjuParser_R155 | EnjuParser_T157 | EnjuParser_T158 | arg1Of | therapy,( |
EnjuParser_R156 | EnjuParser_T159 | EnjuParser_T158 | arg2Of | 66,( |
EnjuParser_R157 | EnjuParser_T167 | EnjuParser_T158 | arg3Of | ),( |
EnjuParser_R158 | EnjuParser_T159 | EnjuParser_T160 | arg1Of | 66,[ |
EnjuParser_R159 | EnjuParser_T162 | EnjuParser_T160 | arg2Of | %,[ |
EnjuParser_R160 | EnjuParser_T163 | EnjuParser_T160 | arg3Of | ],[ |
EnjuParser_R161 | EnjuParser_T162 | EnjuParser_T161 | arg1Of | %,98.5 |
EnjuParser_R162 | EnjuParser_T159 | EnjuParser_T164 | arg1Of | 66,of |
EnjuParser_R163 | EnjuParser_T166 | EnjuParser_T164 | arg2Of | patients,of |
EnjuParser_R164 | EnjuParser_T166 | EnjuParser_T165 | arg1Of | patients,67 |
EnjuParser_R165 | EnjuParser_T157 | EnjuParser_T168 | arg1Of | therapy,and |
EnjuParser_R166 | EnjuParser_T170 | EnjuParser_T168 | arg2Of | therapy,and |
EnjuParser_R167 | EnjuParser_T170 | EnjuParser_T169 | arg1Of | therapy,antibiotic |
EnjuParser_R168 | EnjuParser_T170 | EnjuParser_T171 | arg1Of | therapy,( |
EnjuParser_R169 | EnjuParser_T172 | EnjuParser_T171 | arg2Of | 66,( |
EnjuParser_R170 | EnjuParser_T180 | EnjuParser_T171 | arg3Of | ),( |
EnjuParser_R171 | EnjuParser_T172 | EnjuParser_T173 | arg1Of | 66,[ |
EnjuParser_R172 | EnjuParser_T175 | EnjuParser_T173 | arg2Of | %,[ |
EnjuParser_R173 | EnjuParser_T176 | EnjuParser_T173 | arg3Of | ],[ |
EnjuParser_R174 | EnjuParser_T175 | EnjuParser_T174 | arg1Of | %,98.5 |
EnjuParser_R175 | EnjuParser_T172 | EnjuParser_T177 | arg1Of | 66,of |
EnjuParser_R176 | EnjuParser_T179 | EnjuParser_T177 | arg2Of | patients,of |
EnjuParser_R177 | EnjuParser_T179 | EnjuParser_T178 | arg1Of | patients,67 |
LitCovid-ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 0-120 | DRI_Background | denotes | Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). |
LitCovid-PubTatorCentral
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 5-13 | Species:9606 | denotes | patients |
T12 | 59-67 | Species:9606 | denotes | patients |
T13 | 110-118 | Species:9606 | denotes | patients |
LitCovid-sentences-v1
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T11 | 0-120 | Sentence | denotes | Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). |
LitCovid-TimeML
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
tok172 | 0-4 | JJS | denotes | Most |
tok173 | 5-13 | NNS | denotes | patients |
tok174 | 14-22 | VBD | denotes | received |
tok175 | 23-32 | JJ | denotes | antiviral |
tok176 | 33-40 | NN | denotes | therapy |
tok177 | 41-42 | ( | denotes | ( |
tok178 | 42-44 | CD | denotes | 66 |
tok179 | 45-46 | NN | denotes | [ |
tok180 | 46-48 | CD | denotes | 98 |
tok181 | 48-49 | . | denotes | . |
tok182 | 49-50 | CD | denotes | 5 |
tok183 | 50-51 | NN | denotes | % |
tok184 | 51-52 | NN | denotes | ] |
tok185 | 53-55 | IN | denotes | of |
tok186 | 56-58 | CD | denotes | 67 |
tok187 | 59-67 | NNS | denotes | patients |
tok188 | 67-68 | ) | denotes | ) |
tok189 | 69-72 | CC | denotes | and |
tok190 | 73-83 | JJ | denotes | antibiotic |
tok191 | 84-91 | NN | denotes | therapy |
tok192 | 92-93 | ( | denotes | ( |
tok193 | 93-95 | CD | denotes | 66 |
tok194 | 96-97 | NN | denotes | [ |
tok195 | 97-99 | CD | denotes | 98 |
tok196 | 99-100 | . | denotes | . |
tok197 | 100-101 | CD | denotes | 5 |
tok198 | 101-102 | NN | denotes | % |
tok199 | 102-103 | NN | denotes | ] |
tok200 | 104-106 | IN | denotes | of |
tok201 | 107-109 | CD | denotes | 67 |
tok202 | 110-118 | NNS | denotes | patients |
tok203 | 118-119 | ) | denotes | ) |
tok204 | 119-120 | . | denotes | . |
lookup34 | 50-51 | percent | denotes | % |
lookup35 | 101-102 | percent | denotes | % |
event8 | 14-22 | OCCURRENCE | denotes | received |
MeasurableQuantitativeAnnotation
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
E1 | 23-40 | entity | denotes | antiviral therapy |
E2 | 73-91 | entity | denotes | antibiotic therapy |
N1 | 42-44 | num | denotes | 66 |
N2 | 46-50 | num | denotes | 98.5 |
N3 | 97-101 | num | denotes | 98.5 |
U1 | 50-51 | unit | denotes | % |
U2 | 101-102 | unit | denotes | % |
R5 | N3 | U2 | associateOf | 98.5,% |
R5 | N3 | U2 | associateOf | 98.5,% |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 0-120 | Sentence | denotes | Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). |
T11 | 0-120 | Sentence | denotes | Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). |